Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors.

被引：0
|
作者：
Coyne, Geraldine Helen O'Sullivan
Kummar, Shivaani
Khanh Tu Do
Holbeck, Susan
Hollingshead, Melinda G.
Horneffer, Yvonne
Juwara, Lamin
Srivastava, Apurva K.
Rubinstein, Larry
Piekarz, Richard
Sharon, Elad
Streicher, Howard
Conley, Barbara A.
Antony, Ramya
Collins, Jerry M.
Chen, Alice
Doroshow, James H.
机构：
[1] Early Clin Trials Dev Program, Bethesda, MD USA
[2] Stanford Univ, Sch Med, Phase Clin Res Program 1, Stanford, CA 94305 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
[5] NCI, Div Canc Treatment & Diag, NIH, Frederick, MD 21701 USA
[6] NCI, Bethesda, MD 20892 USA
[7] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD USA
[8] Div Canc Treatment & Diag, Bethesda, MD USA
[9] NCI, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA
[10] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[11] NCI, Rockville, MD USA
[12] Leidos Biomed Res Inc, Frederick, MD USA
[13] NCI, DCTD, Rockville, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2614
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase I study of regorafenib in combination with vincristine and irinotecan in pediatric patients with recurrent or refractory solid tumors.
    Casanova, Michela
    Bautista, Francisco
    Hewson, Quentin Campbell
    Makin, Guy
    Marshall, Lynley V.
    Verschuur, Arnauld
    Canete, Adela
    Corradini, Nadege
    Ploeger, Bart
    Mueller, Udo
    Zebger-Gong, Hong
    Chung, John Woojune
    Geoerger, Birgit
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] A phase I study of sirolimus in combination with metronomic therapy in children with recurrent and refractory solid/CNS tumors.
    Qayed, Muna
    Cash, Thomas
    Tighiouart, Mourad
    MacDonald, Tobey
    Goldsmith, Kelly C.
    Kean, Leslie S.
    Church, Patty
    Katzenstein, Howard M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Phase I clinical trial of XK469 in patients with chemo-refractory solid tumors.
    Alousi, AM
    Parchment, R
    Boinpally, R
    Gadgeel, S
    Weigand, R
    McCormick, J
    Lorusso, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 132S - 132S
  • [24] Phase I trial of daily imatinib mesylate and weekly paclitaxel in patients with advanced refractory solid tumors.
    Moore, DJ
    Bahrani, A
    Hwang, JJ
    Ramzi, P
    Marshall, JL
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (02) : S391 - S391
  • [25] Phase I Trial of Fixed-Dose Rate Gemcitabine in Combination with Bortezomib in Advanced Solid Tumors
    Luu, Thehang
    Chow, Warren
    Lim, Dean
    Koczywas, Marianna
    Frankel, Paul
    Cristea, Mihaela
    Margolin, Kim
    Doroshow, James H.
    Somlo, George
    Gaur, Shikha
    Yen, Yun
    Morgan, Robert J.
    ANTICANCER RESEARCH, 2010, 30 (01) : 167 - 174
  • [26] Phase I trial of bortezomib (PS-341) in combination with docetaxel in patients with advanced solid tumors
    Messersmith, WA
    Baker, SD
    Dinh, K
    Lassiter, LK
    Akdamar, RA
    Wright, JJ
    Donehower, RC
    Carducci, MA
    Armstrong, DK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 208S - 208S
  • [27] A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas
    Kummar, Shivaani
    Ji, Jiuping
    Morgan, Robert
    Lenz, Heinz-Josef
    Puhalla, Shannon L.
    Belani, Chandra P.
    Gandara, David R.
    Allen, Deborah
    Kiesel, Brian
    Beumer, Jan H.
    Newman, Edward M.
    Rubinstein, Larry
    Chen, Alice
    Zhang, Yiping
    Wang, Lihua
    Kinders, Robert J.
    Parchment, Ralph E.
    Tomaszewski, Joseph E.
    Doroshow, James H.
    CLINICAL CANCER RESEARCH, 2012, 18 (06) : 1726 - 1734
  • [28] A phase I study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
    Cash, Thomas
    Jonus, Hunter C.
    Tsvetkova, Maya
    Beumer, Jan Hendrik
    Lee, Jasmine Y.
    Henry, Curtis
    Aguilera, Dolly
    Harvey, R. Donald
    Goldsmith, Kelly C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Phase Ib trial of nivolumab combined with metformin for refractory/recurrent solid tumors.
    Kubo, Toshio
    Hotta, Katsuyuki
    Ninomiya, Takashi
    Kato, Hironari
    Horiguchi, Shigeru
    Takamoto, Atsushi
    Kozuki, Toshiyuki
    Nogami, Naoyuki
    Ishii, Hiroshi
    Nishina, Tomohiro
    Harada, Daijiro
    Toyooka, Shinichi
    Okada, Hiroyuki
    Fujiwara, Toshiyoshi
    Udono, Heiichiro
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] A phase I trial of gemcitabine plus paclitaxel combination therapy in patients with refractory solid tumors
    Sandler, A
    Raghavan, D
    Meropol, N
    Meyers, T
    Kindler, H
    Fox, S
    Perez, R
    Einhorn, LH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1120 - 1120
12345